Definitive Contract 75N95020C00003

Award Date 2/1/20
Potential Completion Date 1/31/25
Potential Value $8M
Funding Federal Agency
National Institute on Aging
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Camden, NJ 08103, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institute on Aging (NIA) awarded a 5-year, $10,513,138 definitive contract to the Coriell Institute for Medical Research, Inc. to continue operating an aging cell repository that provides well-characterized cell lines and DNA to researchers studying the biology of aging. The contract supports maintaining existing cell stocks, establishing new cell lines, isolating DNA, and distributing materials to investigators. There is no set-aside designation for this award. Coriell Institute,...
This is a definitive contract awarded by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency within the U.S. Department of Health and Human Services, to the Coriell Institute for Medical Research, Inc., an independent non-profit biomedical research center. The $11,186,265.00 contract is for the operation of the NINDS Human Genetics Resource Center, which involves receiving, processing, storing, cataloging, and distributing biological samples and associated data...
The Department of Health and Human Services' National Institutes of Health's National Institute on Aging awarded a $125,135 firm fixed price delivery order contract to Life Technologies Corporation, a subsidiary of Thermo Electron Corporation, to generate induced pluripotent stem cell lines. Under the contract, Life Technologies will produce stem cell lines for the agency through October 9, 2022. The award was made without a set-aside designation on May 9, 2022. As the preeminent federal sponsor...
This is a $11,526,996.72 definitive cost-plus-fixed-fee contract awarded by the National Institute on Aging (NIA), a civilian agency within the National Institutes of Health (NIH), to Precision For Medicine, Inc. The contract is for the receipt, storage, management, and distribution of biological specimens. The contract does not have a set-aside designation, indicating full and open competition. Precision For Medicine, Inc. is a specialized scientific services company that has extensive...
This is a $6,060,016.85 cost-plus-fixed-fee contract awarded by the National Institute on Aging (NIA), part of the National Institutes of Health, to Precision For Medicine, Inc. for the NIA Central Biorepository - Biological Specimens Storage project. The contract has an ultimate completion date of July 29, 2023. The contract supports the NIA's establishment of a centralized biorepository to store and manage a large collection of biological specimens and related data from various NIA-funded...
The National Institute on Aging (NIA), a civilian agency of the U.S. government, awarded a $23,006.00 firm-fixed-price purchase order to Creative Biogene Inc., a self-certified small disadvantaged business, to provide laboratory services for the analysis of protein expression and signals in AC8 models. The contract has an ultimate completion date of November 22, 2024. Creative Biogene has a history of providing specialized biotechnology services, including metabolomics analysis, proteomics...
This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. for $17,016.80. The contract was awarded on January 5, 2023 with a completion date of July 5, 2023. The contract supports genetic and epigenetic analysis at the transcriptome level, which is a critical component of the Comprehensive Disease Study (CDS) program's integrative research...
Corebiome, Inc. Diversigen Division was awarded a $24,312.50 firm fixed price purchase order by the National Institutes of Health's National Institute on Aging to provide laboratory and testing services in support of the Institute's research programs. As part of the Department of Health and Human Services, the National Institute on Aging seeks to understand the nature of aging and extend the healthy, active years of life through programs of research, research training, health information...
The federal contract award 75N95D24P00067 was made by the National Institute on Aging (NIA), a civilian agency within the U.S. government, to Reprocell U.S.A., Inc., a for-profit organization, for laboratory testing services related to RNA and DNA extraction from mouse and human models. The $20,902.50 firm fixed price contract has a period of performance through July 30, 2024. The contract was awarded under full and open competition with no set-aside designation. Reprocell U.S.A., Inc. has...
This federal contract award, valued at $249,990.00, was issued by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH) under the Department of Health and Human Services. The prime contractor is 10X Genomics, Inc., a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The award is for the delivery of six (6) Chromium Next GEM Single Cell Multiome ATAC and Gene Expression Reagent...

This is a $7,985,296.56 definitive cost-no-fee contract awarded by the National Institute on Aging (NIA) to the Coriell Institute for Medical Research, Inc. The contract is for the selection, production, characterization, and distribution of cultured cells to support research on aging. Coriell, an independent non-profit biomedical research center, has extensive expertise in areas such as genomics, cell culture, and biospecimen management, making it a valuable partner for the NIA's research activities.

The contract does not have a set-aside designation, reflecting Coriell's specialized capabilities in this domain. Coriell has previously been awarded several significant federal contracts, including an $11.2 million contract with the National Institute of Neurological Disorders and Stroke (NINDS) to operate the NINDS Human Genetics Resource Center, and an $8.6 million contract with the NIA for similar cell culture services. This latest award further demonstrates Coriell's position as a leading provider of biorepository and biospecimen services for federally-funded biomedical research.

Generated 12/17/24, 9:14 AM